4 key points for a better understanding of ICH Q3D approach
Our experience with the implementation of ICH Q3D has showed that the new approach is not always well-understood by suppliers, probably due to the length and complexity of the guideline. This issue provokes a lot of time-consuming actions (hundreds of emails between customer-supplier, fulfilling questionnaires that are not enough for the drug product manufacturer, etc.).…